Matrixyl 3000 Promotional Sheet Usa
Matrixyl 3000 Promotional Sheet Usa
Matrixyl 3000 Promotional Sheet Usa
MATRIXYL 3000
TM
Make-uup
Patented
Pal-G
GHK and Pal-G
GQPR
Function:
Definition:
Properties:
MatrixylTM3000 contains
matrikines which are
messengers of cutaneous
restructuration and repair. They
activate the neosynthesis of
extracellular matrix
macromecules providing
MatrixylTM3000 with a visible
anti-wrinkle efficacy.
Characteristics:
As messenger molecules,
matrikines are capable of
regulating cell activities. They
interact with specific receptors
to activate certain genes
involved in the process of
extracellular matrix renewal
and cell proliferation. With age
these mechanisms become
progressively weaker.
INCI Name:
Glycerin - Butylene Glycol Aqua (Water) - Carbomer Polysorbate-20 Palmitoyl Oligopeptide Palmitoyl Tetrapeptide-3
Applications:
Formulation:
Water soluble
3 to 8%
CLAIM SUBSTANTIATION
January 2004
in vitro tests
Synthesis of matrix macromolecules
Study to determine ability of fibroblasts
incubated for 72 hours with MatrixylTM3000 (1,
3,and 5%) to stimulate synthesis of
extracellular matrix components.
Stimulation of gene expression
Study to evaluate regulation of dermal and
epidermal genes by matrikines present in
MatrixylTM3000, using DNA-Array techniques
on a reconstructed epidermis and a fibroblast
culture.
In vitro
Collagen 1
70
Fibronectin
Hyaluronic Acid
60
50
40
30
20
10
0
in vivo tests
Visible and measurable proof of anti-wrinkle efficacy
Clinical study in which 2 panels of 23 volunteers aged 39 to 74 applied a cream containing 3%
Matrixyl3000 to one-half of their face against a placebo or 3% Matrixyl on the other half twice a day
for 56 days. Anti-wrinkling and lifting efficacy was assessed by profilometry and photography, as
compared to T0.
Variation of parameters compared to T0 (%)
MatrixylTM3000
*significant / T0 (p<0.05)
44.9
37.0**
15.1**
18.5**
14.4**
16.6**
**
MatrixylTM
Placebo
-27.7**
-27.3*
-9.8**
-14.7**
-10.8**
-12.7**
4.3
-9.6
-3.2
-8.7*
1.4
4.2
ns
ns
ns
ns
ns
In vivo
T0 MATRIXYLTM
T56 MATRIXYLTM
Variation / T0 (%)
20
15
10
5
0
MatrixylTM 3000
MatrixylTM
*
*
Placebo
significant / T0
**
Elasticity
T0 MATRIXYLTM3000
T56 MATRIXYLTM3000
Tone
Sederma Inc
E-mail: [email protected]
www.crodausa.com
Tel 732-692-1652
Fax 732-417-0804